DCM
MRNS

DAFNA Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

DAFNA Capital Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-22,559
Closed -$115K – 96
2016
Q2 		$115K Sell
22,559
-119,066
-84% -$2.19M 0.09% 84
2016
Q1 		$3.05M Hold
141,625
– – 2.63% 9
2015
Q4 		$4.33M Buy
141,625
+136,045
+2,438% +$3.99M 3.86% 4
2015
Q3 		$186K Hold
5,580
– – 0.18% 73
2015
Q2 		$259K Buy
+5,580
New +$208K 0.22% 61

Other funds holding MRNS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return